4//SEC Filing
LaFrance Norman D. 4
Accession 0000899243-21-046120
CIK 0001095981other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 9:09 PM ET
Size
5.6 KB
Accession
0000899243-21-046120
Insider Transaction Report
Form 4
LaFrance Norman D.
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy shares of common stock)
2021-11-01+120,000→ 120,000 totalExercise: $120000.00Exp: 2031-11-11→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments.
Documents
Issuer
PLUS THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001397768
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 9:09 PM ET
- Size
- 5.6 KB